Axogen
Open
$42.47
Prev. Close
$42.65
High
$43.03
Low
$42.46
Market Snapshot
$2.23B
-71.0
-0.22
$187.34M
622
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Recently from Cashu
Axogen Faces Mixed Performance Amid Growth Potential in Nerve Repair Market
Axogen (Ticker: AXGN) is a company focused on developing and commercializing products for peripheral nerve regeneration. Recently, it faces mixed performance metrics, indicating a complexity in its cu…
AxoGen Strengthens Peripheral Nerve Repair Market Position Through Strategic Initiatives and Reimbursement Progress
AxoGen Inc (Ticker: AXGN) continues to solidify its position in the peripheral nerve repair market through strategic initiatives and reimbursement progress. Under the leadership of President and CEO M…
Axogen Reports Strong Q4 Growth Driven by Innovative Nerve Repair Product Launches
Axogen Sees Robust Q4 Growth Amid Innovative Product Launches Axogen (NASDAQ: AXGN) demonstrates impressive financial progress in its recently announced Q4 earnings report. The company reports a total…
Divergent Analyst Views on Axogen Highlight Execution and Reimbursement Risks
Divergent analyst readings spotlight Axogen’s execution and reimbursement risks Axogen is facing a sharp divergence in analyst assessments this quarter as six independent research firms issue ratings…